Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1002690 | 0.98 | — | — | |
| SCHEMBL26039174 | 0.98 | — | — | |
| SCHEMBL1838719 | 0.92 | PDK1 (0.47) | PDK1POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL27809443 | 0.89 | PDK1 (0.47) | PDK1POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL25754241 | 0.88 | SMN1; SMN2 (0.46) | PDK1POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL8350616 | 0.87 | — | — | |
| SCHEMBL13301297 | 0.86 | SMN1; SMN2 (0.44) | PDK1POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL812840 | 0.84 | LMNA (0.52) | POLBLMNAALDH1A1SMN1; SMN2HPGD | |
| Alcohol SCHEMBL7527792 | 0.83 | LMNA (0.49) | PDK1POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL16345225 | 0.82 | LMNA (0.50) | POLBLMNAALDH1A1SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101479280-B | Borane ether complexes | BASF AG | 2011-07-13 | — | — | CN | disclosed |
| EP-2035437-B1 | BORANE ETHER COMPLEXES | BASF SE (DE) | 2010-08-18 | — | — | EP | disclosed |
| US-20090278085-A1 | BORANE ETHER COMPLEXES | BASF SE (DE) | 2009-11-12 | — | — | US | disclosed |
| CN-101479280-A | Borane ether complexes | BASF AG (DE) | 2009-07-08 | — | — | CN | disclosed |
| EP-2035437-A1 | BORANE ETHER COMPLEXES | BASF SE (DE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008000678-A1 | BORANE ETHER COMPLEXES | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090278085-A1 | BORANE ETHER COMPLEXES | CBR3, C5, CBR1 | PDK1 2091/4885POLB 4320/4885LMNA 2603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.